ArticleBMJ open2015

Protocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response-adaptive study.

Lucy A Truman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.